Make us your home page

Let's Talk

Connect with

Links for the Times: FDA extends review of breast cancer drug Avastin



What happens if tens of thousands of breast cancer patients, including several in the Tampa Bay area, can no longer use the drug they credit for their survival? In a previous report in the Times, staff writer Martine Powers interviewed patients and doctors. Read our previous coverage, FDA's decision on Avastin is a personal one for breast cancer patients.

[Last modified: Sunday, September 19, 2010 6:38am]


Join the discussion: Click to view comments, add yours